Stephen T. Oh, MD, PhD

Blood Disorders (Hematology)

Top Doctors®

Specializes in

Myeloproliferative neoplasms, polycythemia vera, essential thrombocythemia, myelofibrosis, chronic myeloid leukemia, chronic myelomonocytic leukemia, systemic mastocytosis, hypereosinophilic syndrome

Appointments

Hospital Affiliations

  • Barnes-Jewish Hospital

Experience

Board Certifications

  • Internal Medicine
  • Hematology

Academic Title(s)

Associate Professor, Medicine
Co-Chief, Division of Hematology

Research Interests

Myeloproliferative neoplasms, including the application of single cell mass cytometry to interrogate operturbed signaling networks in MPNs, and the application of next generation sequencing technologies to delineate genomic complexity and clonal evolution in MPNs.

Publications & Research

View research profile »

Education

A.B. (Biochemical Sciences)

1996 Harvard University, Cambridge, MA

Medical Degree

2004 Cancer Biology, Medical Scientist Training Program, Northwestern University Feinberg School of Medicine, Chicago, IL

Residency

2006 Stanford University School of Medicine, Stanford, CA

Fellowship

2010 Hematology/Oncology, Stanford University School of Medicine, Stanford, CA

Financial Disclosures
  • Harmonic Discovery
    • Equity: Yes
    • Reporting Date: 05/01/2025
  • Phoenix Molecular Designs
    • Equity: Yes
    • Reporting Date: 05/01/2025

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

Is this your profile? Request an edit »